Ocular Adverse Events After COVID-19 Vaccination.


Journal

Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169

Informations de publication

Date de publication:
18 Aug 2021
Historique:
pubmed: 25 9 2021
medline: 28 1 2022
entrez: 24 9 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has galvanized the development of new vaccines at an unprecedented pace. Since the widespread implementation of vaccination campaigns, reports of ocular adverse effects after COVID-19 vaccinations have emerged. This review summarizes ocular adverse effects possibly associated with COVID-19 vaccination, and discusses their clinical characteristics and management. Narrative Literature Review. Ocular adverse effects of COVID-19 vaccinations include facial nerve palsy, abducens nerve palsy, acute macular neuroretinopathy, central serous retinopathy, thrombosis, uveitis, multiple evanescent white dot syndrome, Vogt-Koyanagi-Harada disease reactivation, and new-onset Graves' Disease. Studies in current literature are primarily retrospective case series or isolated case reports - these are inherently weak in establishing association or causality. Nevertheless, the described presentations resemble the reported ocular manifestations of the COVID-19 disease itself. Hence, we hypothesize that the human body's immune response to COVID-19 vaccinations may be involved in the pathogenesis of the ocular adverse effects post-COVID-19 vaccination. Ophthalmologists and generalists should be aware of the possible, albeit rare, ocular adverse effects after COVID-19 vaccination.

Identifiants

pubmed: 34559576
doi: 10.1080/09273948.2021.1976221
pmc: PMC8477588
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1216-1224

Auteurs

Xin Le Ng (XL)

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.

Bjorn Kaijun Betzler (BK)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Ilaria Testi (I)

Moorfields Eye Hospital, NHS Foundation Trust, London, UK.

Su Ling Ho (SL)

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.

Melissa Tien (M)

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.

Wei Kiong Ngo (WK)

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.

Manfred Zierhut (M)

Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany.

Soon Phaik Chee (SP)

Department of Ocular Inflammation and Immunology, Singapore National Eye Centre, Singapore.
Singapore Eye Research Institute, The Academia, Singapore.
Department of Ophthalmology & Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore.

Vishali Gupta (V)

Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Carlos E Pavesio (CE)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Marc D de Smet (MD)

MicroInvasive Ocular Surgery Clinic, Lausanne, Switzerland.
Department of Ophthalmology, University of Leiden, Leiden, The Netherlands.

Rupesh Agrawal (R)

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Department of Ocular Inflammation and Immunology, Singapore National Eye Centre, Singapore.
Singapore Eye Research Institute, The Academia, Singapore.
Department of Ophthalmology & Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH